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Abstract: Fungi are known to produce a vast array of secondary metabolites that are gaining importance for 
their  biotechnological applications.  Screening  of Aspergillus gorakhpurensis for the production  of bioactive 
secondary metabolites results in the production of 4-(N-methyl-N-phenyl amino) butan-2-one and itaconic acid. 
The structure of the known compounds was established by 
1H-, 
13C-NMR and Mass spectral data. Biological 
evaluation of the two compounds against test microorganisms showed strong inhibitory activity of 4-(N-methyl-
N-phenyl  amino)  butan-2-one  towards  bacteria  and  fungi.  Only  4-(N-methyl-N-phenyl  amino)-butan-2-one 
showed a marked significant activity (LD50 = 330.69 µg/mL) in Spodoptera litura larvicidal bioassay. 
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1. Fungal Source 
 
Microbial natural products remain the most promising source of novel secondary metabolites. 
The impact of microbial biodiversity favours the chance of isolating new antibiotics. Identification of 
microorganisms that produce bioactive compounds is of great interest in the development of new 
molecules to fight against many pathogens. Fungi produce a wide range of secondary metabolites with 
high therapeutic value as antibiotics, cytotoxic substances, insecticides, compounds that promote or 
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inhibit growth, attractor, repellent etc., [1]. These metabolites are being exploited in different fields of 
medicine and industries [2]. Among fungi classes, Ascomycetes are reported to be active producers of 
antimicrobial compounds, which have high therapeutic values [3]. Within our screening program for 
antimicrobaial and larvicidal fungal secondary  metabolites, we investigated  an Ascomycetes fungi 
Aspergillus gorakhpurensis (MTCC 547) procured from Microbial Type Culture Collection (MTCC), 
IMTECH, Chandigarh, India, for chemical and biological studies. The fungus was cultivated for 7 
days on potato dextrose broth medium and the culture was extracted with ethyl acetate. 
 
2. Previous Studies 
 
There is no previous studies on the metabolites of this fungus. 
 
3. Present Study 
 
In the present study Aspergillus gorakhpurensis MTCC 547 was procured from Microbial 
Type Culture Collection (MTCC), IMTECH, Chandigarh India and exploited for the production of 
secondary metabolites. A portion of mature agar slant was inoculated in one liter of potato dextrose 
broth in 2 liter Erlenmeyer flask and incubated at 27 ± 2 º C as resting cell suspension for 7 days. The 
fermented broth (8 L) was treated with ethyl acetate (V: V) and incubated overnight. The mixture 
(fermented broth and solvent) was shaken vigorously for 30 min and kept in stationary condition for 
another 30 min to separate the solvent from aqueous phase. The organic extract was separated, dried 
over anhydrous sodium sulfate and concentrated in vacuo to yield crude (2.1 g). 
Activated silica gel (60–120 mesh) was packed on to a glass column (450 mm × 40 mm) using 
n-hexane solvent and 2.1 g of crude ethyl acetate extract was loaded on the top of silica gel column. 
The column was eluted with the mixture of hexane and ethyl acetate (8:2). Fractions that showed 
homogeneity  on  TLC  plates  were  combined  and  concentrated  together  to  give  pure  compounds. 
Fraction  1 (54  mg)  and  Fraction  2  (31  mg)  were  obtained.  The  pure  fractions  were  subjected  to 
Chemical characterization using Nuclear magnetic resonance spectroscopy (
1H- & 
13C-NMR) (Bruker 
UXNMR  at  300MHz  in  CDCl3)  and  Mass  spectroscopy  (Finnigan  MAT  1020-B  in  CDCl3).  The 
metabolites were identified as -(N-methyl-N-phenyl amino) butan-2-one; C11H15NO; Mol.wt.177.0 (1) and 
Itaconic acid; C5H6O4; Mol.wt.130.1 (2) (Figure 1). 
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Figure. 1 Chemical structures of -(N-methyl-N-phenyl amino) butan-2-one and Itaconic acid 
 
 
4-(N-methyl-N-phenyl amino) butan-2-one (C11H15NO):  
1H NMR (300MHz, CDCl3): δ : 2.13 (3H, s), 
2.67 (2H, t, J=6.798), 2.91 (2H, s), 3.61 (2H, t, J=6.798), 6.60 (3H, m), 7.12 (2H, t, J=7.554). 
13C 
NMR (300MHz, CDCl3): δ : 30.54, 38.90, 40.28, 47.56, 112.74, 117.05, 129.35, 148.40, 206.29. 
 
Itaconic acid (C13H26O):  
1H NMR (300MHz, CDCl3): δ: 3.21 (2H, s), 5.65 (1H, s), 6.23 (1H, s), 11.34 
(2H, s). 
13C NMR (300MHz, CDCl3): δ :36.87, 126.47, 134.47, 167.02, 171.58. Busi et al., Rec. Nat. Prod. (2009) 3:3 161-164  
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Bioactivity Tests 
 
Antibacterial activity evaluated against Gram-positive organisms and Gram-negative bacteria 
by  well  diffusion  method  [4].  Solutions  were  prepared  (50-150  µg/mL)  by  dissolving  the  test 
compounds in dimethyl sulfoxide (DMSO) and add to appropriate well. The petri dishes with treated 
and the control cups were incubated at 37°C for 24 h. The zones of inhibition diameters (mm) were 
measured. Triplicates performed for each treatment. Control experiment carried out with the pure 
solvent. Antifungal activity was carried out in similar manner using zone of inhibition method against 
eight fungal strains according to the method of Linday. 
The minimum inhibitory concentration was determined according to the method described by 
Andrews [5].  Different concentrations  (200-10  µg/mL)  of  isolated compounds and  100 µL  of  the 
bacterial suspension (10
-5 CFU/mL) were placed aseptically in10 mL of nutrient broth separately and 
incubated for 24 h at 37 °C. The growth was observed both visually and by measuring O.D. at 600 nm. 
The lowest concentration of test sample showed no visible growth was recorded as the minimum 
inhibitory  concentration.  Duplicate  sets  of  tubes  were  maintained  for  each  concentration  of  test 
sample. 
Larvicidal activity (measured as mortality after 24 h) of the   compounds was determined by 
topical application to early fourth instars according to Laurin et.al [6]. Lethality was estimated by 
applying different concentrations (50 to 1000 µg/mL) of the metabolites. Two replicates of 10 larvae 
were tested per dose. A probit analysis was carried out to calculate LD50 and LD90 [7]. 
The antimicrobial activity of the isolated compounds against all the test organisms had shown 
in the Table. 4-(N-methyl-N-phenyl amino) butan-2-one showed strong antibacterial activity against 
gram-positive  bacteria  i.e.  Staphylococcus  aureus,  Staphylococcus  epidermides  and  gram-negative 
bacteria i.e. Escherichia coli with zone of inhibition between 15 to 18 mm at a concentration of 100 
µg/mL. The MIC  value of the 4-(N-methyl-N-phenyl amino) butan-2-one was 100 µg/mL against 
Staphylococcus aureus and Staphylococcus epidermides. 4-(N-methyl-N-phenyl amino) butan-2-one 
was tested for anti fungal activity against eight fungi and showed moderate activity against all fungi 
except Candida albicans (15 mm). Whereas Itaconic acid showed antibacterial and antifungal activity 
at very higher concentrations (150 µg/mL). 4-(N-methyl-N-phenyl amino) butan-2-one showed potent 
lethality against Spodoptera litura 4
th instar larvae (Table). The data was further subjected to probit 
analysis and the LC50 value calculated to be 330.69 µg/mL.  
In  conclusion,  we have reported the isolation  of two known  compounds  from  Aspergillus 
gorakhpurensis.  The  antimicrobial  and  larvicidal  activities  of  the  isolated  pure  compounds  were 
reported.  The  isolated  compounds  showed  moderate  antimicrobial  and  insecticidal  activities. 
Microbial  secondary  metabolites  represent  a  large  source  of  compounds  endowed  with  ingenious 
structures and potent biological activities. Many of the products currently used for human or animal 
therapy, in animal husbandry and in agriculture are produced by microbial fermentation, or derived 
from  chemical  modification  of  a  microbial  product  [8].  The  present  study  of  screening  bioactive 
secondary metabolites revealed that Aspergillus gorakhpurensis as a source for the production of two 
bioactive metabolites. These metabolites can be further exploited for the biotechnological applications 
in medicine and agriculture. 
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Table 1.  Antibacterial, antifungal and larvicidal bioassay of 4-(N-methyl-N- phenyl amino) butan-2-
one and Itaconic acid 
   Zone of inhibition  MIC (µg/mL) 
   (1)  (2)  Control 
30 µg  (1)  (2)  Control 
Bacteria  50 µg  100 µg  100 µg  150 µg  Penicillin-G        Nitrofurantoin 
Gram Positive Bacteria                          
S. aureus MTCC 96  15  18  -  8  18  100  >200  50 µg/mL 
S. epidermides MTCC 435   14  16  -  -  18  100  >200  50 µg/mL 
B. subtilis MTCC 441  12  14  -  -  20  150  >200  100 µg/mL 
B. sphericus MTCC 511  12  14  -  -  20  150  >200  100 µg/mL 
Gram Negative Bacteria               Streptomycin         
E. coli MTCC 443  13  15  -  -  29  150  >200  50 µg/mL 
P. aeruginosa MTCC 741  12  14  -  -  34  150  >200  75 µg/mL 
P. oleovorans MTCC 617  12  14  -  -  30  150  >200  75 µg/mL 
K. pneumoniae MTCC 39  12  14  -  -  30  150  >200  50 µg/mL 
Fungi            Larvicidal assay 
Filamentous fungi              Clotrimazole   (1) 
A. niger MTCC 1344  10  12  -  -  22  LD50  330.69 µg/mL 
A. parasiticus MTCC 411   10  12  -  -  22  LD90  1132.62µg/mL 
R. oryzae MTCC 262  12  14  10  12  23  (2) 
C. cladosporides MTCC 2607   10  12  -  -  20  LD50  >1000 µg/mL 
Unicellular fungi                 LD90  >1000 µg/mL 
C. albicans MTCC 227  13  15  8  10  18  Control (Pyrethrum) 
C. albicans MTCC 3018  13  15  -  8  18  LD50  1.6 µg/mL 
S. cerevisiae MTCC 170  12  14  -  -  19  LD90  3.0 µg/mL 
S. cerevisiae MTCC 171  12  14  -  -  19       
(1)= 4-(N-methyl-N-phenyl amino) butan-2-one; (2)= Itaconic acid. Zone of inhibition was calculated in mm. 
LD50 = Lethal concentration (µg/mL) at which 50 % of the larvae showed mortality. 
Negative control DMSO-No activity. 
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